Schilke Tobin

Avg. Two Year Performance

No purchase track record
15% Avg. Sale Return
7% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(8%)16%49%25%15%
Sale Success Rate1 of 42 of 43 of 42 of 41 of 4
Drugs » Biotechnology

CFO:

Holdings: 39.56K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Chief Financial Officer:

Holdings: 47.75K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--